Nancy Myers, JD
CEO, Founder
Nancy Bradish Myers, JD, is a widely respected consultant, strategist, and Board member with deep expertise in health care law, medical product regulation, and health policy. As the Founder and CEO of Catalyst Healthcare Consulting, she has led the firm for over two decades, positioning it at the forefront of strategic regulatory policy and innovation.
With a career spanning three decades in Washington, D.C., Ms. Myers has built a reputation for anticipating regulatory trends, shaping policy strategies, and influencing decision-making at the highest levels. She works closely with Board members, executive leadership teams, and regulatory affairs professionals, advising on issues ranging from crisis management to long-term policy and business strategy.
A sought-after speaker and author, Ms. Myers is committed to elevating critical regulatory and policy challenges across the healthcare industry, patient advocacy, and government sectors. She is known for her ability to forge strong relationships with thought leaders, assemble high-impact expert teams, and drive consensus across diverse stakeholder groups.
Nancy is passionate about crafting creative solutions to regulatory challenges posed by groundbreaking scientific innovation. For years, she has worked to shape policies that enhance patient access to life-changing therapies, leveraging her extensive expertise across federal agencies, industry associations, health insurance, and investment research. Her career has included key leadership roles in the biopharmaceutical industry, financial sector, and government affairs, including serving as Special Counsel for Scientific Policy at PhRMA, Vice President and Political Healthcare Analyst at Lehman Brothers, Reimbursement Counsel and Director of Government Affairs at BIO, and Senior Lobbyist for Blue Cross Blue Shield Association/BCBS of NJ. She also spent time on Capitol Hill, gaining firsthand experience in the legislative process.
Before founding Catalyst, Ms. Myers served in multiple roles at the U.S. Food and Drug Administration (FDA), most recently as Special Assistant and Senior Strategic Advisor in the Office of the Commissioner. She continues to maintain strong relationships with FDA leadership and staff, actively supporting the agency through her work with nonprofit organizations and advocacy coalitions - including the Alliance for a Stronger FDA and the FDA Alumni Association.
